Jonathan D. Schoenfeld, MD, MPH, physician, assistant professor of Radiation Oncology, Harvard Medical School, Dana Farber Cancer Institute on the immunologic effects of chemotherapy and radiation in head and neck cancer.

Immune checkpoint blockage has demonstrated some exciting results in head and neck cancer, says Schoenfeld. However, that work has been largely done in metastatic head and neck cancer. Schoenfeld and his team studied the immunologic effects of chemotherapy and radiation, which are typically given in early-stage head and neck cancer.

What they found is the combination of chemotherapy and radiation, and in some cases radiation alone, led to immune effects not just in the site that was radiated, but also in markers in the peripheral blood.

View more from the 2016 Multidisciplinary Head and Neck Cancer Symposium

Conference

® Conference page includes a listing of all conferences covered by 

, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.


Head & Neck Cancers

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer. 

Multidisciplinary Head and Neck Cancer Symposium

Jonathan D. Schoenfeld, MD, MPH, physician, assistant professor of Radiation Oncology, Harvard Medical School, Dana Farber Cancer Center on the immunologic effects of chemotherapy and radiation in head and neck cancer.


Dr. Schoenfeld on Immunologic Effects of Chemotherapy and Radiation in Head and Neck Cancer